News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
1don MSN
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Kennedy Jr.'s announcement that the Centers for Disease Control and Prevention will no longer recommend COVID vaccines for ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
The Covid-19 vaccine remains on the CDC's revised schedule of childhood vaccinations despite HHS Secretary Robert F. Kennedy ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback